Knockdown of lncRNA AGPG disrupts the formation of the PURα/E2F1 complex, releasing E2F1 from the PURα/E2F1 complex, leading to the activation of the E2F1 signaling pathway, which promotes BC cell cycle progression and endocrine resistance (Yu et al. 2023). The gene discussed is E2F1; the disease is breast cancer.